Continental Pharma Incorporated

Midit, Societe Fiduciaire

Daniel M Matagne

Joseph L Roba

Georges E Lambelin

Paul J Niebes

Michel R Franz

Andras B Vincze

Etienne T Hanon

Etienne P Hanon

Drug for treating affections provoked by a too high histamine level in the body, for treating affections of the gastroduodenal mucosa and allergic affections, comprising the reaction product of (+)-catechin with at least one basic amino-acid, which is more particularly selected from the group consisting of L-lysine, L-arginine and L-ornithine.

Drug for treating affections provoked by a too high histamine level, of

A salt of (+)-catechin formed of the reaction product of (+)-catechin with at least a basic amino-acid, such as L-lysine and L-arginine; a hydrosoluble double salt is formed by the reaction product of (+)-catechin with a basic amino-acid, such as L-lysine and L-arginine, and another inorganic or organic acid.

Salts of (+)-catechine, their preparation and use, and compositions

A pharmaceutical composition for treating degenerative diseases of the articular cartilage, in particular osteoarthritis and chondromalacia, and of the degenerative processes of the articular cartilage resulting from other diseases, such as rheumatoid arthritis, this composition containing (+) - catechin and/or one of the salts thereof as an active products, said composition being administered orally, rectally, intra-articularly, intravenously or topically.

Pharmaceutical composition and therapeutical method for treating

Growing community of inventors

Taviers, Belgium

Daniel M Matagne